In addition, numerous case reports have provided evidence suggesting a potential association between the utilization of TNF-α inhibitors and a higher occurrence of non-melanoma skin cancer (NMSC), specifically squamous cell carcinoma [7,22]. This evidence concerns the gene TNF and non-melanoma skin carcinoma.